{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:57:26Z","timestamp":1790816246278,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"DOI":"10.7759\/cureus.52559","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T13:16:45Z","timestamp":1705670205000},"source":"Crossref","is-referenced-by-count":28,"title":["Diagnosis and Treatment of Ankylosing Spondylitis"],"prefix":"10.7759","author":[{"given":"Parv","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Tote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagyesh","family":"Sapkale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14956.1","article-title":"Recent advances in ankylosing spondylitis: understanding the disease and management","volume":"7","author":"Garcia-Montoya L","year":"2018","unstructured":"Garcia-Montoya L, Gul H, Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Res. 2018, 7:10.12688\/f1000research.14956.1","journal-title":"F1000Res"},{"key":"ref2","article-title":"Ankylosing spondylitis: an update","volume":"42","author":"Golder V","year":"2013","unstructured":"Golder V, Schachna L. Ankylosing spondylitis: an update. Aust Fam Physician. 2013, 42:780-4.","journal-title":"Aust Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01232","article-title":"Editorial: ankylosing spondylitis and related immune-mediated disorders","volume":"10","author":"Fiorillo MT","year":"2019","unstructured":"Fiorillo MT, Haroon N, Ciccia F, Breban M. Editorial: ankylosing spondylitis and related immune-mediated disorders. Front Immunol. 2019, 10:1232. 10.3389\/fimmu.2019.01232","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.04.006","article-title":"Genetics and the causes of ankylosing spondylitis","volume":"43","author":"Hanson A","year":"2017","unstructured":"Hanson A, Brown MA. Genetics and the causes of ankylosing spondylitis. Rheum Dis Clin North Am. 2017, 43:401-14. 10.1016\/j.rdc.2017.04.006","journal-title":"Rheum Dis Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1918345","article-title":"Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking","volume":"53","author":"Zhang J","year":"2021","unstructured":"Zhang J, Zhou Y, Ma Z. Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking. Ann Med. 2021, 53:1090-8. 10.1080\/07853890.2021.1918345","journal-title":"Ann Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.822582","article-title":"Editorial: advances in pathogenesis, etiology, and therapies for ankylosing spondylitis","volume":"12","author":"Chen CW","year":"2021","unstructured":"Chen CW, Wei JC, Gu J, Yu D. Editorial: advances in pathogenesis, etiology, and therapies for ankylosing spondylitis. Front Immunol. 2021, 12:822582. 10.3389\/fimmu.2021.822582","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.623874","article-title":"IL-23 inhibition in ankylosing spondylitis: where did it go wrong?","volume":"11","author":"Baeten D","year":"2020","unstructured":"Baeten D, Adamopoulos IE. IL-23 inhibition in ankylosing spondylitis: where did it go wrong?. Front Immunol. 2020, 11:623874. 10.3389\/fimmu.2020.623874","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.614255","article-title":"Why inhibition of IL-23 lacked efficacy in ankylosing spondylitis","volume":"12","author":"McGonagle D","year":"2021","unstructured":"McGonagle D, Watad A, Sharif K, Bridgewood C. Why inhibition of IL-23 lacked efficacy in ankylosing spondylitis. Front Immunol. 2021, 12:614255. 10.3389\/fimmu.2021.614255","journal-title":"Front Immunol"},{"key":"ref9","article-title":"Exercise and ankylosing spondylitis with New York modified criteria: a systematic review of controlled trials with meta-analysis","volume":"39","author":"Martins NA","year":"2014","unstructured":"Martins NA, Furtado GE, Campos MJ, Leit\u00e3o JC, Filaire E, Ferreira JP. Exercise and ankylosing spondylitis with New York modified criteria: a systematic review of controlled trials with meta-analysis. Acta Reumatol Port. 2014, 39:298-308.","journal-title":"Acta Reumatol Port"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key128","article-title":"Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis","volume":"58","author":"van der Heijde D","year":"2019","unstructured":"van der Heijde D, Braun J, Deodhar A, et al.. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology (Oxford). 2019, 58:388-400. 10.1093\/rheumatology\/key128","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1561281","article-title":"The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond","volume":"15","author":"Dubash S","year":"2019","unstructured":"Dubash S, Bridgewood C, McGonagle D, Marzo-Ortega H. The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond. Expert Rev Clin Immunol. 2019, 15:123-34. 10.1080\/1744666X.2019.1561281","journal-title":"Expert Rev Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbre.2016.09.009","article-title":"Swiss ball exercises improve muscle strength and walking performance in ankylosing spondylitis: a randomized controlled trial","volume":"57","author":"Souza MC","year":"2017","unstructured":"Souza MC, Jennings F, Morimoto H, Natour J. Swiss ball exercises improve muscle strength and walking performance in ankylosing spondylitis: a randomized controlled trial. Rev Bras Reumatol Engl Ed. 2017, 57:45-55. 10.1016\/j.rbre.2016.09.009","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref13","article-title":"[Ankylosing spondylitis]","volume":"18","author":"Mitsui H","year":"2008","unstructured":"Mitsui H. [Ankylosing spondylitis]. Clin Calcium. 2008, 18:1781-5.","journal-title":"Clin Calcium"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001888","article-title":"Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades","volume":"7","author":"Crossfield SS","year":"2021","unstructured":"Crossfield SS, Marzo-Ortega H, Kingsbury SR, Pujades-Rodriguez M, Conaghan PG. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open. 2021, 7:e001888. 10.1136\/rmdopen-2021-001888","journal-title":"RMD Open"},{"key":"ref15","article-title":"Ankylosing spondylitis: field in progress","volume":"14","author":"Slobodin G","year":"2012","unstructured":"Slobodin G, Rosner I, Rimar D, Boulman N, Rozenbaum M, Odeh M. Ankylosing spondylitis: field in progress. Isr Med Assoc J. 2012, 14:763-7.","journal-title":"Isr Med Assoc J"},{"key":"ref16","article-title":"Imaging of axial spondyloarthritis. New aspects and differential diagnoses","volume":"36 Suppl 114","author":"Braun J","year":"2018","unstructured":"Braun J, Baraliakos X, Buehring B, Kiltz U, Fruth M. Imaging of axial spondyloarthritis. New aspects and differential diagnoses. Clin Exp Rheumatol. 2018, 36 Suppl 114:35-42.","journal-title":"Clin Exp Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.suppl_3.iii8","article-title":"Ankylosing spondylitis: an overview","volume":"61 Suppl 3","author":"Sieper J","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002, 61 Suppl 3:iii8-18. 10.1136\/ard.61.suppl_3.iii8","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8048-21","article-title":"Dagger sign in ankylosing spondylitis","volume":"61","author":"Mukai T","year":"2022","unstructured":"Mukai T, Morita Y. Dagger sign in ankylosing spondylitis. Intern Med. 2022, 61:765. 10.2169\/internalmedicine.8048-21","journal-title":"Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23964","article-title":"Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis","volume":"35","author":"Wu J","year":"2021","unstructured":"Wu J, Yan L, Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal. 2021, 35:e23964. 10.1002\/jcla.23964","journal-title":"J Clin Lab Anal"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5817.46","article-title":"Ankylosing spondylitis","volume":"3","author":"Sambrook DK","year":"1972","unstructured":"Sambrook DK. Ankylosing spondylitis. Br Med J. 1972, 3:46. 10.1136\/bmj.3.5817.46","journal-title":"Br Med J"},{"key":"ref21","article-title":"Ankylosing spondylitis. Not just another pain in the back","volume":"50","author":"Maksymowych WP","year":"2004","unstructured":"Maksymowych WP. Ankylosing spondylitis. Not just another pain in the back. Can Fam Physician. 2004, 50:257-62.","journal-title":"Can Fam Physician"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05794.x","article-title":"Ankylosing spondylitis: recent developments and anaesthetic implications","volume":"64","author":"Woodward LJ","year":"2009","unstructured":"Woodward LJ, Kam PC. Ankylosing spondylitis: recent developments and anaesthetic implications. Anaesthesia. 2009, 64:540-8. 10.1111\/j.1365-2044.2008.05794.x","journal-title":"Anaesthesia"},{"key":"ref23","unstructured":"Ankylosing spondylitis-ankylosing spondylitis - symptoms & causes. (2023). Accessed. August 19, 2023: https:\/\/www.mayoclinic.org\/diseases-conditions\/ankylosing-spondylitis\/symptoms-causes\/syc-20354808."},{"key":"ref24","unstructured":"Ankylosing spondylitis (AS). symptoms, causes & treatment. (2020). Accessed: August 19, 2023: https:\/\/my.clevelandclinic.org\/health\/diseases\/16595-ankylosing-spondylitis-as."},{"key":"ref25","article-title":"Genomics of ankylosing spondylitis","volume":"10","author":"Thomas GP","year":"2010","unstructured":"Thomas GP, Brown MA. Genomics of ankylosing spondylitis. Discov Med. 2010, 10:263-71.","journal-title":"Discov Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624632","article-title":"From the genetics of ankylosing spondylitis to new biology and drug target discovery","volume":"12","author":"Nancy Z","year":"2021","unstructured":"Nancy Z, Yan L, Hui S, Paul B, Liye C. From the genetics of ankylosing spondylitis to new biology and drug target discovery. Front Immunol. 2021, 12:624632. 10.3389\/fimmu.2021.624632","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.116","article-title":"Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman","volume":"32","author":"Suh YS","year":"2017","unstructured":"Suh YS, Kim HO, Cheon YH, Jo W, Hong J, Lee SI. Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman. Korean J Intern Med. 2017, 32:374-7. 10.3904\/kjim.2015.116","journal-title":"Korean J Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa250","article-title":"Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis","volume":"59","author":"Poddubnyy D","year":"2020","unstructured":"Poddubnyy D. Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology (Oxford). 2020, 59:iv6-iv17. 10.1093\/rheumatology\/keaa250","journal-title":"Rheumatology (Oxford)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1401-79","article-title":"Treatment of ankylosing spondylitis","volume":"45","author":"Sari \u0130","year":"2015","unstructured":"Sari \u0130, \u00d6zt\u00fcrk MA, Akko\u00e7 N. Treatment of ankylosing spondylitis. Turk J Med Sci. 2015, 45:416-30. 10.3906\/sag-1401-79","journal-title":"Turk J Med Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002822.pub3","article-title":"Physiotherapy interventions for ankylosing spondylitis","volume":"2008","author":"Dagfinrud H","year":"2008","unstructured":"Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev. 2008, 2008:CD002822. 10.1002\/14651858.CD002822.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183949-diagnosis-and-treatment-of-ankylosing-spondylitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:50Z","timestamp":1707509570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183949-diagnosis-and-treatment-of-ankylosing-spondylitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.52559","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}